Results Press Release
Cadila Healthcare Ltd has informed BSE that has submitted to BSE a copy of Results Press Release for the period ended March 31, 2015.15-05-2015
15-05-2015
Fixes Book Closure for Dividend & AGM
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 03, 2015 to August 12, 2015 (both days inclusive) for the purpose of Payment of Dividend & 20th Annual General Meeting (AGM) of the Company to be held on August 12, 2015. Date from which the dividend is payable: On or after August 17, 2015.15-05-2015
Auditors Report for March 31, 2015
Cadila Healthcare Ltd has informed BSE that has submitted to BSE a Copy of the Auditors Report for the period ended March 31, 2015.15-05-2015
Board recommends Dividend
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2015, inter alia, have recommended a dividend of Rs. 12/- (@ 240%) per equity share on 204,748,520 equity shares of Rs. 5/- on March 31, 2015.15-05-2015
Announces Q4 & FY15 results
Cadila Healthcare Ltd has announced the following results for the quarter & year ended March 31, 2015:The Audited results for the Quarter ended March 31, 2015The Company has posted a net profit of Rs. 3470.60 million for the quarter ended March 31, 2015 as compared to Rs. 2166.80 million for the quarter ended March 31, 2014. Total Income has increased from Rs. 11218.90 million for the quarter ended March 31, 2014 to Rs. 14688.50 million for the quarter ended March 31, 2015....15-05-2015
Zydus to present New Clinical Data on Lipaglyn at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress in Nashville, TN, USA
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated May 12, 2015 titled "Zydus to present New Clinical Data on Lipaglyn at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress in Nashville, TN, USA".12-05-2015
FY15 results on May 15, 2015
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 15, 2015, inter alia, to consider 1. To approve the audited stand-alone and consolidated financial results for the quarter / year ended on March 31, 2015 and 2. To recommend the dividend on equity shares of the Company for the financial year ended on March 31, 2015....27-04-2015
Zydus Group to donate USD 240,000 to The National Institutes of Health, USA for advancing leishmaniasis research
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated April 23, 2015 titled "Zydus Group to donate USD 240,000 to The National Institutes of Health, USA for advancing leishmaniasis research"23-04-2015
Cadila Healthcare seeks nod to raise 10,000 cr from markets
Sends ballot notice to have enabling approvals in place to meet funding needs13-04-2015